The Wellcome Sanger Institute is a genomics research institute based at the Wellcome Genome Campus in Cambridge, UK. Founded in 1992 by the Wellcome Trust, it operates at the intersection of large-scale data generation and biomedical research, working across human genetics, cancer biology, infectious disease, and biodiversity. Its infrastructure is built around high-throughput genome sequencing and computational analysis of genomic data at scale - the kind of environment where technology is not merely a support function but central to the science itself.
The Institute made the largest single contribution to the Human Genome Project, completing the first draft of the human genome by 2000. It has since expanded its scope considerably. Research is organised into six scientific programmes: Cellular Genomics, Generative Genomics, Human Genetics, Parasites and Microbes, Somatic Genomics, and Tree of Life. The last of these has contributed to sequencing the genomes of hundreds of species, in many cases for the first time. During the COVID-19 pandemic, the Institute also played a significant role in genomic surveillance efforts.
A strong commitment to open-access data sharing runs throughout its work. Genomic data and research outputs are made broadly available to the scientific community, a principle that has shaped the Institute's practices since its earliest work on the human genome. This open model underpins collaborations across academia, public health, and industry worldwide.